Excerpt
JUDY WOODRUFF (NewsHour): When you see headlines about a new drug on the market, chances are you have rarely thought about the gender of the lab animal the drug was first tested on during trials, but, in fact, most early trials are conducted on male rats or other male animals.
Researchers say that gender difference has led to a significant impact after a drug comes to market. Last week, the National Institutes of Health announced that it is requiring scientists to test their work on both male and female animals.
For some insight into what’s behind these changes and what it means, we turn to Dr. Janine Clayton. She’s the director of the National Institutes of Health’s Office of Research on Women’s Health. That’s the agency that announced the change. And Phyllis Greenberger, she’s the president of the Society for Women’s Health Research. She has long advocated for this change.
No comments:
Post a Comment